...
首页> 外文期刊>Nursing research >Systematic Review of Self-Monitoring of Blood Glucose in Patients With Type 2 Diabetes
【24h】

Systematic Review of Self-Monitoring of Blood Glucose in Patients With Type 2 Diabetes

机译:Systematic Review of Self-Monitoring of Blood Glucose in Patients With Type 2 Diabetes

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The benefit of self-monitoring of blood glucose in reducing HbA_1c in non-insulin-treated participants remains unclear. HbA_1c may be improved in this population with said self-monitoring. Objective: The aim of this study was to conduct meta-analyses of glycemic control in non-insu lin-treated participants with Type 2 diabetes: self-monitoring of blood glucose versus usual care, structured versus unstructured self-monitoring of blood glucose, and use of self-monitoring of blood glucose readings by clinicians to adjust (or modify) therapy versus usual care. Methods: MEDLINE, Embase, and Cochrane Central were electronically searched to identify articles published from January 1, 2000, to June 30, 2020. Trials investigating changes in HbA_1c were selected. Screening was performed independently by two investigators. Two investigators extracted HbA_1c at baseline and follow-up for each trial. Results: Nineteen trials involving 4,965 participants were included. Overall, self-monitoring of blood glucose reduced HbA_1c. Preplanned subgroup analysis showed that using self-monitoring of blood glucose readings to adjust therapy contributed significantly to the reduction. No significant improvement in HbA_1c was shown in self-monitoring of blood glucose without therapy adjustment. The same difference was observed in structured versus unstructured self-monitoring of blood glucose. Discussion: HbA_1c is improved with clinician therapy modification based on structured self-monitoring of blood glucose readings. Implications are for clinicians to prescribe structured self-monitoring of blood glucose to modify therapy based on the readings and not prescribe unstructured self-monitoring of blood glucose. Participants with suboptimal glycemic control may benefit most. A self-monitoring of blood glucose regimen that improves clinical and cost-effectiveness is presented. Future studies can investigate this regimen specifically.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号